News
11d
Zacks Investment Research on MSNIs Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Novavax Inc. closed 61.59% short of its 52-week high of $17.81, which the company achieved on July 26th.
Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.
Novavax stock was up on Monday amid roiling uncertainty about its Covid-19 vaccine approval, which has been caught up in the turbid health politics of the second Trump administration. Novavax said ...
Novavax faces a couple of key issues that could be crucial for the stock price. Novavax ( NVAX 0.67% ) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a ...
Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at what's going on.
Novavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the healthcare stock are up 200% since the start of May.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results